, Volume 46, Issue 6, pp 871–874 | Cite as

Fecal microbiota transplantation in a kidney transplant recipient with recurrent urinary tract infection

  • Lena M. Biehl
  • Rebeca Cruz Aguilar
  • Fedja Farowski
  • Werner Hahn
  • Angela Nowag
  • Hilmar Wisplinghoff
  • Maria J. G. T. VehreschildEmail author
Case Report



We report on a kidney transplant recipient treated with fecal microbiota transplantation (FMT) for recurrent urinary tract infections.


FMT was administered via frozen capsulized microbiota. Before and after FMT, urinary, fecal and vaginal microbiota compositions were analyzed.


The patient remained without symptoms after FMT.


Underlying mechanisms of action need to be addressed in depth by future research.


Recurrent urinary tract infection Fecal microbiota transplantation Urinary microbiome Non-antibiotic prophylaxis 



We thank the patient for provision of clinical data and Anastasia Tsakmaklis and Fabiola Sack for excellent laboratory support.


This work was supported by the German Research Foundation (DFG) [BI 1899/1-1].

Compliance with ethical standards

Conflict of interest

LMB has received lecture honoraria from Astellas and Merck/MSD, and travel grants from 3M and Gilead. MJGTV reports grants and personal fees from Astellas Pharma, Merck/MSD, Gilead Sciences, Berlin Chemie, Falk Foundation, Organobalance, Pfizer, and grants from Astellas Pharma, Merck/MSD, Seres Therapeutics, DaVolterra. All other authors: none to declare.


  1. 1.
    Hooton TM. Recurrent urinary tract infection in women. Int J Antimicrob Agents. 2001;17:259–68.CrossRefGoogle Scholar
  2. 2.
    Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13:269–84. Scholar
  3. 3.
    Stapleton AE, Au-Yeung M, Hooton TM, Fredricks DN, Roberts PL, Czaja CA, et al. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin Infect Dis. 2011;52:1212–7. Scholar
  4. 4.
    Sundén F, Håkansson L, Ljunggren E, Wullt B. Escherichia coli 83972 bacteriuria protects against recurrent lower urinary tract infections in patients with incomplete bladder emptying. J Urol. 2010;184:179–85. Scholar
  5. 5.
    Tariq R, Pardi DS, Tosh PK, Walker RC, Razonable RR, Khanna S. Fecal microbiota transplantation for recurrent clostridium difficile infection reduces recurrent urinary tract infection frequency. Clin Infect Dis. 2017;65:1745–7. Scholar
  6. 6.
  7. 7.
    Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJA, Holmes SP. DADA2: High-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13:581. Scholar
  8. 8.
    R Core Team. R: a language and environment for statistical computing. 3.2.5 ed. Vienna: R Foundation for Statistical Computing; 2016.Google Scholar
  9. 9.
    Tacke D, Wisplinghoff H, Kretzschmar A, Farowski F, Koehler P, Herweg J, et al. First implementation of frozen, capsulized faecal microbiota transplantation for recurrent Clostridium difficile infection into clinical practice in Europe. Clin Microbiol Infect. 2015;21:e82–4. Scholar
  10. 10.
    Schreiber HL, Conover MS, Chou WC, Hibbing ME, Manson AL, Dodson KW, et al. Bacterial virulence phenotypes of Escherichia coli and host susceptibility determine risk for urinary tract infections. Sci Transl Med. 2017. Scholar
  11. 11.
    Whiteside SA, Razvi H, Dave S, Reid G, Burton JP. The microbiome of the urinary tract—a role beyond infection. Nat Rev Urol. 2015;12:81–90. Scholar
  12. 12.
    den Heijer CD, Beerepoot MA, Prins JM, Geerlings SE, Stobberingh EE. Determinants of antimicrobial resistance in Escherichia coli strains isolated from faeces and urine of women with recurrent urinary tract infections. PLoS One. 2012;7:e49909. Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department I of Internal MedicineUniversity Hospital of CologneCologneGermany
  2. 2.German Centre for Infection Research, Partner Site Bonn-CologneCologneGermany
  3. 3.Practice for Nephrology and Hypertension, DialysisMayenGermany
  4. 4.Wisplinghoff LaboratoriesCologneGermany
  5. 5.Institute for Medical Microbiology, Immunology and HygieneUniversity of CologneCologneGermany
  6. 6.Institute for Virology and Medical MicrobiologyWitten/Herdecke UniversityWittenGermany

Personalised recommendations